Q4 FY25 Results Roundup: Earnings Highlights from India's Top Companies

Q4 FY25 Results Roundup: Earnings Highlights from India's Top Companies

The fourth quarter earnings season for FY25 has unveiled a mixed bag of results across sectors, reflecting the evolving macroeconomic landscape, sector-specific tailwinds, and challenges. From narrowing losses and strategic turnarounds to margin compression and market misses, here's a comprehensive look at the most significant Q4 highlights as of May 22, 2025.

Top Gainers & Outperformers

1. ITC Ltd.

• Net Profit: ₹19,561.6 Cr (vs ₹5,020 Cr YoY)

• Revenue: ₹18,494 Cr (↑9.4% YoY)

• EBITDA: ₹5,986.3 Cr (↑2.5% YoY)

• Margin: 32.4%

• Highlight: Exceptional gain of ₹15,179.4 Cr from discontinued operations.

ITC beat revenue estimates but missed on EBITDA margin. The board recommended a final dividend of ₹7.85/share.

2. Mtar Technologies

• Net Profit: ₹13.7 Cr (↑185% YoY)

• Revenue: ₹183 Cr (↑28% YoY)

• EBITDA: ₹34 Cr (↑86.8% YoY)

• Margin: 18.6%

Strong demand and improved operational efficiencies drove significant bottom-line growth.

3. Power Mech Projects

• Net Profit: ₹129.8 Cr (↑53.8% YoY)

• Revenue: ₹1,875.3 Cr (↑42.4% YoY)

• EBITDA: ₹215.7 Cr (↑44.3% YoY)

The infrastructure firm maintained stable margins at 11.6% despite a sharp scale-up in operations.

4. Emcure Pharmaceuticals

• Net Profit: ₹189 Cr (↑64.4% YoY)

• Revenue: ₹2,116 Cr (↑19.5% YoY)

Strong domestic and export performance helped Emcure deliver robust earnings.

5. Strides Pharma Science

• Net Profit: ₹85.6 Cr (vs ₹10.4 Cr YoY)

• Revenue: ₹1,190 Cr (↑14% YoY)

• US Revenue: $77 Mn (↑23%)

• FY25 Revenue Growth: 17.2% (vs 12–15% guidance)

Post-demerger operational efficiencies are paying off. The company beat its full-year guidance.

Notable Misses & Underperformers

1. Grasim Industries

• Net Loss: ₹288 Cr (vs ₹441 Cr YoY)

• Revenue: ₹8,926 Cr (↑31.9%)

• EBITDA: ₹221 Cr (↓58.1%)

• Margins: 2.5% vs 7.8%

Despite revenue growth, Grasim missed profit estimates and saw major margin erosion.

2. Ramco Cements

• Net Profit: ₹31 Cr (↓74.5% YoY)

• Revenue: ₹2,392 Cr (↓10.5%)

• EBITDA: ₹320.8 Cr (↓23%)

• Margin: 13.4%

Demand slowdown and higher costs impacted performance; missed Street estimates.

3. HFCL

• Net Loss: ₹81.4 Cr (vs ₹110 Cr profit YoY)

• Revenue: ₹800.7 Cr (↓39.6%)

• EBITDA: Loss of ₹36 Cr

A sharp drop in revenues and operating profit turned the bottom line negative.

4. Honasa Consumer (Mamaearth)

• Net Profit: ₹25 Cr (↓17.8% YoY)

• Revenue: ₹533.5 Cr (↑13.3%)

• EBITDA: ₹26.9 Cr (↓18.5%)

Despite top-line growth, margin pressure and rising costs affected profitability.

Stable Players & Mixed Performance

1. Container Corporation of India (CONCOR)

• Net Profit: ₹298.5 Cr (↓1.6% YoY)

• Revenue: ₹2,287.8 Cr (↓1.6%)

• Bonus Issue: 1:4

Flat performance, but a bonus share issue was announced to reward shareholders.

2. Sun Pharmaceutical Industries

• Net Profit: ₹2,153.9 Cr (↓19% YoY)

• Revenue: ₹12,958.8 Cr (↑8.1%)

• EBITDA: ₹3,715.9 Cr (↑22.4%)

• Margin: 28.7%

Strong EBITDA growth and margin improvement, but missed profit expectations.

3. Metro Brands

• Net Profit: ₹95.3 Cr (↓38.8% YoY)

• Revenue: ₹642.8 Cr (↑10.3%)

• EBITDA: ₹197.2 Cr (↑24.3%)

Revenue and EBITDA up, but bottom line under pressure due to rising costs.

Emerging Trends and Market Buzz

• Udaipur Cement posted a 108% surge in profits.

• Dwarikesh Sugar and Deepak Fertilisers reported strong double-digit growth.

• Clean Science, Subros, and Sandhar Technologies posted stable gains.

• Colgate-Palmolive, HFCL, and Indoco Remedies saw sharp stock reactions due to weak earnings.

• Fortis Healthcare, VRL Logistics, and VA Tech Wabag shares surged on strong operating performance.

Conclusion

The Q4 FY25 earnings season reflects a mixed macro backdrop. While several manufacturing and pharma names posted strong recoveries or exceeded guidance, others—particularly in cement, telecom equipment, and FMCG—faced margin compression or demand-side headwinds. With dividend declarations, bonus issues, and FY26 guidance beginning to trickle in, investor focus now shifts to strategic clarity and growth sustainability.

Stay tuned for more sector-specific deep dives and company analysis as the season unfolds.